You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stage IV adenocarcinoma of the breast

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GVHD Trial (Grafalon, Thymoglobulin)

Not yet recruiting
  • GVHD
  • (no location specified)
Oct 9, 2023

Opiate Withdrawal Syndrome Trial in Zagazig (Venlafaxine, Lofexidine)

Completed
  • Opiate Withdrawal Syndrome
  • Zagazig, Sharkia, Egypt
    Faculty of medicine
Oct 5, 2022

Atrial Fibrillation, Arrhythmias, Cardiac Trial in Chios (Flecainide Injectable Product)

Completed
  • Atrial Fibrillation
  • Arrhythmias, Cardiac
  • Flecainide Injectable Product
  • Chios, Greece
    Skylitseio General Hospital
Aug 4, 2021

Haemorrhoids Trial in Zalau (diosmin and micronized flavonoids, Placebo)

Not yet recruiting
  • Haemorrhoids
  • diosmin and micronized flavonoids
  • Placebo
  • Zalău, Salaj, Romania
    SC Salvosan Ciobanca SRL
Feb 28, 2023

Graft-versus-host Disease (GVHD) Trial in Worldwide (Itacitinib, Placebo, Prednisone)

Completed
Has Results
  • Graft-versus-host Disease (GVHD)
  • La Jolla, California
  • +128 more
Jul 13, 2021

Breast Abnormalities Trial in New York (Contrast Enhanced Spectral Mammography (CESM))

Active, not recruiting
  • Breast Abnormalities
  • Contrast Enhanced Spectral Mammography (CESM)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 10, 2022

Acute Kidney Disease Trial in Taipei City (Azacitidine, Placebo)

Not yet recruiting
  • Acute Kidney Disease
  • Taipei City, Taiwan
    Yu Hsiang Chou
May 2, 2022

Ischemic Stroke Trial in Beijing (improvement of quality of stroke care)

Completed
  • Ischemic Stroke
  • improvement of quality of stroke care
  • Beijing, Beijing, China
    Beijing Tiantan Hospital, Capital Medical University
Oct 26, 2021

Airway Inflammation, Asthma Trial in United Kingdom (SYMBICORT and salbutamol)

Active, not recruiting
  • Airway Inflammation
  • Asthma
  • SYMBICORT and salbutamol
  • Bradford, United Kingdom
  • +5 more
Aug 22, 2022

Malignant Solid Tumor Trial in Beijing, Linyi (ASKB589 Injection)

Active, not recruiting
  • Malignant Solid Tumor
  • ASKB589 Injection
  • Beijing, Beijing, China
  • +1 more
Feb 25, 2021

Cerebral Contributions to Symptom Progression in PD

Active, not recruiting
  • Parkinson Disease
    • Nijmegen, Gelderland, Netherlands
      Donders institute for brain, cognition and behaviour
    Dec 8, 2021

    Breast Cancer, Chemotherapeutic Agent Toxicity, Palmar-plantar Erythrodysesthesia Trial in San Francisco (Nicotine patch)

    Terminated
    Has Results
    • Breast Cancer
    • +2 more
    • Nicotine patch
    • San Francisco, California
      University of California, San Francisco
    Sep 11, 2020

    Refractory Multiple Myeloma, Smoldering Multiple Myeloma, Stage I Multiple Myeloma Trial in Duarte (radiation, drug, procedure,

    Completed
    Has Results
    • Refractory Multiple Myeloma
    • +4 more
    • total marrow irradiation
    • +8 more
    • Duarte, California
      City of Hope Medical Center
    Feb 25, 2021

    Colon Cancer Trial in Svendborg (right sided hemicolectomy, laparoscopy)

    Not yet recruiting
    • Colon Cancer
    • right sided hemicolectomy, laparoscopy
    • Svendborg, Southern Denmark, Denmark
      Issam al-Najami
    Feb 3, 2022

    Tumors, Rectal Trial (Dostarlimab)

    Not yet recruiting
    • Neoplasms, Rectal
    • Dostarlimab
    • (no location specified)
    Feb 2, 2023

    Breastfeeding, Exclusive, Pain, Acute, Maternal Distress Trial in Farmington, Hartford (The BSM Intervention, Attention Control)

    Recruiting
    • Breastfeeding, Exclusive
    • +4 more
    • The BSM Intervention
    • Attention Control
    • Farmington, Connecticut
    • +1 more
    Jun 15, 2022

    Anemia Trial in New York (Ferumoxytol injection)

    Recruiting
    • Anemia
    • Ferumoxytol injection
    • New York, New York
      NYU Langone Health
    Aug 11, 2022

    Lung Cancer, Advanced Cancer Trial in Changsha (Acceptance and Commitment Therapy (ACT), Usual care)

    Completed
    • Lung Cancer
    • Advanced Cancer
    • Acceptance and Commitment Therapy (ACT)
    • Usual care
    • Changsha, Hunan, China
      Xiangya Hospital Central South University
    Oct 3, 2022

    EvaluatioN of durvALumab Utilization and Effectiveness for First

    Recruiting
    • Small Cell Lung Carcinoma
    • Angers, France
    • +24 more
    Jan 12, 2023

    Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in United States (Behavioral Intervention, Quality-of-Life

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • Malignant Solid Neoplasm
    • Behavioral Intervention
    • +2 more
    • Decatur, Illinois
    • +4 more
    May 17, 2022

    Metastatic Breast Cancer Trial in Indianapolis (Acceptance and Commitment Therapy, Education/Support)

    Recruiting
    • Metastatic Breast Cancer
    • Acceptance and Commitment Therapy
    • Education/Support
    • Indianapolis, Indiana
      Indiana University Simon Cancer Center
    Dec 29, 2021

    Adult Burkitt Lymphoma, B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Burkitt Lymphoma, DLBCL

    Active, not recruiting
    Has Results
    • Adult Burkitt Lymphoma
    • +4 more
    • Chicago, Illinois
    • +4 more
    Feb 17, 2022

    Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Charlotte (Transarterial embolization, Microwave Ablation)

    Terminated
    Has Results
    • Hepatocellular Carcinoma
    • +4 more
    • Transarterial embolization
    • Microwave Ablation
    • Charlotte, North Carolina
      Carolinas Medical Center
    Apr 20, 2022

    Anxiety Trial in Torrance (Psilocybin (drug), Active Niacin Placebo)

    Completed
    • Anxiety
    • Psilocybin (drug)
    • Active Niacin Placebo
    • Torrance, California
      Harbor-UCLA Medical Center
    Apr 14, 2022

    FibroLamellar Carcinoma: an International Registry Study

    Not yet recruiting
    • Fibrolamellar Cancer of the Liver
    • Registry of Therapy of patient's diagnosed with FibroLamellar
    • (no location specified)
    Feb 7, 2023